Yang P, Wang H, Meng L, Kou Y, Bu J, Li M
J Mol Histol. 2025; 56(2):86.
PMID: 39928245
DOI: 10.1007/s10735-025-10358-x.
Ben Mrid R, El Guendouzi S, Mineo M, El Fatimy R
Cell Death Discov. 2025; 11(1):50.
PMID: 39915450
PMC: 11802826.
DOI: 10.1038/s41420-025-02323-0.
Zhang L, Thalakiriyawa D, Liu J, Yang S, Wang Y, Dissanayaka W
Stem Cell Res Ther. 2025; 16(1):25.
PMID: 39865283
PMC: 11770943.
DOI: 10.1186/s13287-025-04149-0.
Pu M, Xiao X, Lv S, Ran D, Huang Q, Zhou M
Hereditas. 2025; 162(1):9.
PMID: 39856747
PMC: 11762078.
DOI: 10.1186/s41065-025-00365-z.
Li N, Wei X, Dai J, Yang J, Xiong S
Mol Cell Biochem. 2025; .
PMID: 39853661
DOI: 10.1007/s11010-025-05208-z.
Multimodal tumor suppression by METTL3 gene knockdown in melanoma and colon cancer cells.
Bazargani A, Taha M, Mohammad Soltani B, Javeri A
Histochem Cell Biol. 2024; 163(1):21.
PMID: 39720980
DOI: 10.1007/s00418-024-02346-1.
N6-methyladenosine (m6A) modification in inflammation: a bibliometric analysis and literature review.
Li Z, Lao Y, Yan R, Guan X, Bai Y, Li F
PeerJ. 2024; 12:e18645.
PMID: 39686999
PMC: 11648684.
DOI: 10.7717/peerj.18645.
METTL3 Promotes Osteogenic Differentiation of Human Periodontal Ligament Stem Cells Under the Inflammatory Microenvironment Through the miR-141-3p/ZEB1 Axis.
Li W, Alimujiang A
Cell Biochem Biophys. 2024; .
PMID: 39681812
DOI: 10.1007/s12013-024-01586-1.
METTL3-Mediated m6A Methylation of USP21 Contributes to Hepatocellular Carcinoma Progression by Stabilizing H2BFS Through Deubiquitination.
Yao P, Li X, Chai J, Dong J, Chen Y, Zhang T
Biochem Genet. 2024; .
PMID: 39680331
DOI: 10.1007/s10528-024-10992-2.
METTL3 as a potential therapeutic target in gastric cancer.
Yu Z, Yang Y
Front Oncol. 2024; 14:1483435.
PMID: 39678510
PMC: 11638058.
DOI: 10.3389/fonc.2024.1483435.
Role of m6A Methylation Regulators in the Diagnosis and Subtype Classification of COPD Based on the GEO Database.
Zhang P, Gao N, Li X, Zheng X, Kong D, Wu J
J Cell Mol Med. 2024; 28(22):e70226.
PMID: 39580709
PMC: 11585962.
DOI: 10.1111/jcmm.70226.
Huaier promotes sensitivity of colorectal cancer to oxaliplatin by inhibiting METTL3 to regulate the Wnt/β‑catenin signaling pathway.
Huo M, Gao Z, Wang G, Hou Z, Zheng J
Oncol Rep. 2024; 53(1).
PMID: 39513580
PMC: 11574703.
DOI: 10.3892/or.2024.8840.
METTL3 accelerates staphylococcal protein A (SpA)-induced osteomyelitis progression by regulating m6A methylation-modified miR-320a.
Gao D, Shi J, Lu S, Li J, Lv K, Xu Y
J Orthop Surg Res. 2024; 19(1):729.
PMID: 39506767
PMC: 11542406.
DOI: 10.1186/s13018-024-05164-2.
Regulatory Network of Methyltransferase-Like 3 in Stem Cells: Mechanisms and Medical Implications.
Zeng Y, Wang F, Li S, Song B
Cell Transplant. 2024; 33:9636897241282792.
PMID: 39466679
PMC: 11528761.
DOI: 10.1177/09636897241282792.
Regulation of mA (N-Methyladenosine) methylation modifiers in solid cancers.
Singh S, Gupta S, Abhishek R, Sachan M
Funct Integr Genomics. 2024; 24(6):193.
PMID: 39438339
DOI: 10.1007/s10142-024-01467-z.
METTL3 facilitates the progression of cervical cancer by m6A modification-mediated up-regulation of NEK2.
Guo Y, Bai Y, Wang L, Xu Z, Zhang N, Wang W
Sci Rep. 2024; 14(1):24469.
PMID: 39424828
PMC: 11489587.
DOI: 10.1038/s41598-024-73601-7.
Virtual Screening and Molecular Docking: Discovering Novel METTL3 Inhibitors.
Yang J, He Y, Kang Y, Shen L, Zhang W, Yan Y
ACS Med Chem Lett. 2024; 15(9):1491-1499.
PMID: 39291017
PMC: 11403746.
DOI: 10.1021/acsmedchemlett.4c00216.
The METTL3/TRAP1 axis as a key regulator of 5-fluorouracil chemosensitivity in colorectal cancer.
Kang Q, Hu X, Chen Z, Liang X, Xiang S, Wang Z
Mol Cell Biochem. 2024; 480(3):1865-1889.
PMID: 39287889
PMC: 11842504.
DOI: 10.1007/s11010-024-05116-8.
Influence of RNA Methylation on Cancerous Cells: A Prospective Approach for Alteration of In Vivo Cellular Composition.
Rupareliya M, Shende P
Adv Exp Med Biol. 2024; 1474():79-103.
PMID: 39259424
DOI: 10.1007/5584_2024_820.
Paternal hypercholesterolemia elicits sex-specific exacerbation of atherosclerosis in offspring.
Hernandez R, Li X, Shi J, Dave T, Zhou T, Chen Q
JCI Insight. 2024; 9(17).
PMID: 39253968
PMC: 11385100.
DOI: 10.1172/jci.insight.179291.